Literature DB >> 1503665

Recent developments in the management of paracetamol (acetaminophen) poisoning.

J Janes1, P A Routledge.   

Abstract

Paracetamol (acetaminophen) poisoning accounts for almost a third of admissions to our district poisons unit, and is the commonest cause of death in such patients. Antidotal treatment may be effective up to 10h after overdose with oral methionine or up to 24h with acetylcysteine (not 15h as previously suggested for the latter). Patients taking paracetamol overdose while also receiving drugs which induce hepatic enzymes are more susceptible to liver damage, and antidotal treatment may be necessary at lower plasma paracetamol concentrations (50% of the normal treatment line). As survival following liver transplantation is now increasing, it is important to identify early prognostic indicators in fulminant hepatic failure, so that those patients with a high chance of fatal outcome can be considered for transplantation. Useful indicators are the presence of acidosis, marked prolongation of prothrombin time or a continued rise in prothrombin time on day 4 after the overdose. There is no evidence that paracetamol or acetylcysteine are teratogenic in pregnancy. Delays in administering acetylcysteine after paracetamol poisoning in pregnancy have been shown to increase the risk of spontaneous abortion and fetal death. Thus, acetylcysteine should be started as early as possible where treatment is indicated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1503665     DOI: 10.2165/00002018-199207030-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  39 in total

1.  Paracetamol overdose in man: relationship between pattern of urinary metabolites and severity of liver damage.

Authors:  M Davis; C J Simmons; N G Harrison; R Williams
Journal:  Q J Med       Date:  1976-04

2.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

3.  Evidence for the involvement of N-acetyl-p- quinoneimine in acetaminophen metabolism.

Authors:  D J Miner; P T Kissinger
Journal:  Biochem Pharmacol       Date:  1979-11-15       Impact factor: 5.858

4.  Acetaminophen toxicity.

Authors:  E Fernandez; A C Fernandez-Brito
Journal:  N Engl J Med       Date:  1977-03-10       Impact factor: 91.245

5.  The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage.

Authors:  L F Prescott; J W Donovan; D R Jarvie; A T Proudfoot
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Paracetamol metabolites in the neonate following maternal overdose.

Authors:  I Roberts; M J Robinson; M Z Mughal; J G Ratcliffe; L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

7.  Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

Authors:  J G O'Grady; A E Gimson; C J O'Brien; A Pucknell; R D Hughes; R Williams
Journal:  Gastroenterology       Date:  1988-05       Impact factor: 22.682

8.  Hypersensitivity-like reactions to N-acetylcysteine.

Authors:  M Tenenbein
Journal:  Vet Hum Toxicol       Date:  1984

9.  Potentiation of acetaminophen hepatotoxicity by alcohol.

Authors:  C J McClain; J P Kromhout; F J Peterson; J L Holtzman
Journal:  JAMA       Date:  1980-07-18       Impact factor: 56.272

10.  Factors contributing to mortality in paracetamol-induced hepatic failure.

Authors:  J Canalese; A E Gimson; M Davis; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1981-01-17
View more
  11 in total

Review 1.  Treatment of acute liver failure.

Authors:  K H Boeker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

2.  Deaths from low dose paracetamol poisoning. Executive action is needed to change national guidelines.

Authors:  J Barnes; M Abban; P Howarth
Journal:  BMJ       Date:  1998-12-12

Review 3.  The human and economic cost of paracetamol (acetaminophen) overdose.

Authors:  G R Bond; J E Novak
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

4.  Random and systematic medication errors in routine clinical practice: a multicentre study of infusions, using acetylcysteine as an example.

Authors:  R E Ferner; N J Langford; C Anton; A Hutchings; D N Bateman; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

Review 5.  Utility of acetylcysteine in treating poisonings and adverse drug reactions.

Authors:  P A Chyka; A Y Butler; B J Holliman; M I Herman
Journal:  Drug Saf       Date:  2000-02       Impact factor: 5.606

Review 6.  Therapeutic drug monitoring in drug overdose.

Authors:  A H Dawson; I M Whyte
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

7.  Abnormal serum transaminases following therapeutic doses of acetaminophen in the absence of known risk factors.

Authors:  D Kwan; W R Bartle; S E Walker
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 8.  Choosing the right analgesic. A guide to selection.

Authors:  Timothy G Bushnell; Douglas M Justins
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

9.  Paracetamol (acetaminophen) poisoning. No need to change current guidelines to accident departments.

Authors:  P Routledge; J A Vale; D N Bateman; G D Johnston; A Jones; A Judd; S Thomas; G Volans; L F Prescott; A Proudfoot
Journal:  BMJ       Date:  1998-12-12

10.  Should a lower treatment line be used when treating paracetamol poisoning in patients with chronic alcoholism?: a case for.

Authors:  Nicholas A Buckley; Jayasri Srinivasan
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.